| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |